Zenvision Pharma

Mumbai, India Founded: 2015 • Age: 11 yrs
Provides pharmaceutical formulation development and contract manufacturing services globally.

About Zenvision Pharma

Zenvision Pharma is a Healthcare company based in Mumbai (India) founded in 2015 by B V Sivakumar. It provides pharmaceutical formulation development and contract manufacturing services globally. It operates on a B2B model. Its chief executive, as recorded, is B V Sivakumar. Its Indian entity Msp Medicines Llp reported revenue of β‚Ή27.90 Cr. Zenvision Pharma offers products and services including Formulation Development, Contract Manufacturing, Analytical Development, and Technology Transfer. Its focus areas include Pharmaceuticals, CDMO, Formulation Development and Manufacturing. Its competitors include Syngene, Piramal Group and Panacea Biotec; 1 of its 3 listed competitors has raised funding.

Company details

Zenvision Pharma is a comprehensive CDMO specializing in formulation and product development for highly regulated markets like the US and Europe, as well as semi-regulated ones. It operates with state-of-the-art RD and manufacturing facilities in Navi Mumbai, India, and has an office in Leicester, UK. The company focuses on services including contract manufacturing, analytical development, and technology transfer, emphasizing quality, innovation, and sustainable practices to support global pharmaceutical partners.

Key Metrics
  • Annual Revenue
    ₹27.90 Cr

    FY 2023

  • Net Profit
    ₹4.89 Cr

    FY 2023 · 18% margin

  • EBITDA
    ₹10.38 Cr

    FY 2023 · 37% margin

  • Employee Count
    98

Products & Services of Zenvision Pharma

Zenvision Pharma offers a comprehensive portfolio of products and services, including Formulation Development, Contract Manufacturing, Analytical Development, and Technology Transfer.

Formulation Development
R&D Services

Develops pharmaceutical formulations for regulated and semi-regulated markets

Contract Manufacturing
Manufacturing Services

Produces pharmaceutical products under contract for partners

Analytical Development
Testing Services

Conducts analytical testing for product quality and compliance

Technology Transfer
Knowledge Services

Transfers technology for efficient product scaling and production

Board of directors of Msp Medicines Llp (Zenvision Pharma)

Msp Medicines Llp is the primary company behind Zenvision Pharma. The board of Msp Medicines Llp currently have 2 directors; the longest-serving is Sunil Haripant Pophale, appointed in 2015. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Sunil Haripant Pophale
DIN 00064412
Designated Partner19 Jun 201511 yrs 5 moMsp Medicines Llp
Paras Vinod Gandhi
DIN 10140597
Partner01 Sep 20206 yrs 2 moMsp Medicines Llp

People of Zenvision Pharma

1 people are tracked at Zenvision Pharma (1 in leadership); the tracked headcount is 98.

NameRoleGroup
B V Sivakumar
Co-Founder, CEOLeadership
Premium access

Complete people profiles for Zenvision Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Zenvision Pharma

Figures of Msp Medicines Llp, the primary company behind Zenvision Pharma, for FY 2023. Revenue was ₹27.90 Cr. Net profit was ₹4.89 Cr (18% margin). EBITDA was ₹10.38 Cr (37% margin). Revenue has grown at a compounded annual rate of +51% over three years and +83% over five years.

  • ₹27.90 CrRevenue · FY 2023
  • ₹4.89 CrNet profit · 18% margin
  • ₹10.38 CrEBITDA · 37% margin
  • 98Employees (provident fund records)
  • +51%Revenue CAGR, 3 years
  • +83%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Msp Medicines Llp are on its company page.

Premium access

Detailed financial statements for Zenvision Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Zenvision Pharma

Zenvision Pharma has 3 listed competitors in our database, 1 of them funded. They include Syngene, Piramal Group and Panacea Biotec.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
syngeneintl.com1993Bengaluru, India$85.89M5,618
Provider of contract research and manufacturing services for both small molecules and biologics
piramal.com1984Mumbai, India204
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
panaceabiotec.com1984Ambala, India2,095
Developer of biosimilars, vaccines and natural products
Premium access

Detailed competitors of Zenvision Pharma

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Zenvision Pharma

Zenvision Pharma was founded in 2015.

Zenvision Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

B V Sivakumar is the CEO of Zenvision Pharma, as recorded in our data. They have also founded this company.

Zenvision Pharma has 98 employees.

The primary company behind Zenvision Pharma, Msp Medicines Llp, reported revenue of β‚Ή27.90 Cr for FY 2023.

Zenvision Pharma is a comprehensive CDMO specializing in formulation and product development for highly regulated markets like the US and Europe, as well as semi-regulated ones. It operates with state-of-the-art RD and manufacturing facilities in Navi Mumbai, India, and has an office in Leicester, UK. The company focuses on services including contract manufacturing, analytical development, and technology transfer, emphasizing quality, innovation, and sustainable practices to support global pharmaceutical partners.

Zenvision Pharma's top competitors include Syngene, Panacea Biotec and Piramal Group.

Zenvision Pharma offers Formulation Development, Contract Manufacturing, Analytical Development, and Technology Transfer.

Zenvision Pharma operates through Msp Medicines Llp.

The legal entities of Zenvision Pharma currently have 2 directors, including Sunil Haripant Pophale, Paras Vinod Gandhi.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available